Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Rallybio Corporation
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||
Equity | Common stock, $0.0001 par value per share | Rules 457(c) and 457(h) | 1,891,478 (2) | $1.75 (3) | $3,310,087 | 0.00014760 | $489 | |||||||
Total Offering Amounts | $3,310,087 | $489 | ||||||||||||
Total Fee Offsets | — | |||||||||||||
Net Fee Due | $489 |
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement on Form S-8 (“Registration Statement”) shall also cover any additional shares of the common stock of Rallybio Corporation (the “Registrant”) that become issuable in respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the Registrant’s receipt of consideration that results in an increase in the number of the outstanding shares of the Registrant’s common stock. |
(2) | Represents additional shares of the Registrant’s common stock automatically reserved and available for issuance under the Registrant’s 2021 Equity Incentive Plan (the “2021 Plan”) resulting from the annual “evergreen” increase in the number of authorized shares reserved and available for issuance under the 2021 Plan on January 1, 2024. The annual increase was equal to five (5%) percent of the number of shares of stock issued and outstanding on January 1, 2024. |
(3) | Estimated in accordance with Rules 457(c) and (h) of the Securities Act, solely for the purpose of calculating the registration fee. The proposed maximum offering price per share of $1.75 was computed by averaging the $1.86 (high) and $1.63 (low) prices of a share of the Registrant’s common stock as reported on The Nasdaq Global Select Market on March 12, 2024. |